New England Journal

Bulgaria's Institute for Computer Science, Artificial Intelligence and Technology (INSAIT) has achieved a historic milestone, with an unprecedented 16 articles accepted for the prestigious Conference on Computer Vision and Pattern Recognition (CVPR), the world's foremost forum for AI and computer vision.

A drug that has been used for decades to treat allergic asthma and hives significantly reduced the risk of life-threatening reactions in children with severe food allergies who were exposed to trace amounts of peanuts, cashews, milk and eggs, researchers reported Sunday.

The US Food and Drug Administration on Jan. 6 approved a highly anticipated new drug designed to slow cognitive decline in patients in mild and early stages of Alzheimer's disease.

People with advanced Parkinson's disease often struggle to walk more than a few steps or sleep through the night, but new research offers hope of relief from these two debilitating symptoms.

Suffered by millions worldwide, the degenerative disease erodes motor functions and in its later stages often confines patients to a bed or wheelchair.

Over the past month, Israel, the world's most heavily vaccinated country (with leading mRNA jabs, no less) has seen the number of positive COVID tests has risen by more than 30x as the number of active infections in the country has surpassed 10,000.

Τι έδειξε μελέτη που δημοσιεύθηκε στην επιστημονική επιθεώρηση New England Journal of Medicine

U.S. experts voted on Dec. 10 to recommend granting emergency approval for Pfizer-BioNTech's Covid-19 vaccine, paving the way for America to become the next country to move ahead with mass immunization.

It comes as the worst-hit country in the world logged nearly 6,000 virus deaths in 48 hours and its overall toll was approaching 300,000.

Stanford Club of Greece will hold the first of a "virtual" speaker series titled "Deconstructing Covid-19, re-constructing the economy," on Wednesday, May 27, at 7 p.m.

After a study, US scientists found that by 2030, nearly half of the older Americans will be overweight, BTA reported. The problem of obesity turned out to be more serious than expected.

Scientists found that a drug named Kisqali (ribociclib) is effective in fighting breast cancer. This is the result of a study involving patients affected by HER2-negative breast cancer that is sensitive to hormone therapy. This is reported by BTA.